Literature DB >> 7521034

Ventricular arrhythmia factors in mitral valve prolapse.

D Babuty1, P Cosnay, J C Breuillac, J C Charniot, C Delhomme, L Fauchier, J P Fauchier.   

Abstract

To assess the prevalence of ventricular arrhythmias and late potentials (LPs) in mitral valve prolapse (MVP) and to identify clinical, ECG, and echocardiographic markers of spontaneous ventricular arrhythmias, we studied 58 consecutive patients (mean age 46.6 +/- 17.8 years; 29 males, 29 females) with MVP diagnosed by echocardiography. Patients underwent ambulatory ECG recording (n = 58), exercise stress test (n = 56), signal-averaged ECG (n = 58), and programmed ventricular stimulation (n = 52). Ten patients (17.2%) had spontaneous nonsustained ventricular tachycardia (NSVT), 26 patients (44.8%) had premature ventricular contractions (PVCs), Lown grade > or = 3 during 24-hour ECG, and 19 had Lown grade > or = 3 PVCs during exercise stress test; 13 patients had LPs (22.4%). We provoked sustained VT in one case and NSVT in ten cases. Patients with complex ventricular arrhythmias during 24-hour ECG and exercise stress test were older and more often had mitral regurgitation. There was a statistical correlation between the presence of LPs and spontaneous VT (46.1% vs 8.9%; P < 0.005) and induced ventricular arrhythmias (50% vs 12.8%; P < 0.005). No correlation was found between spontaneous ventricular arrhythmias and thickness or posterior displacement of the mitral valve. In conclusion, complex ventricular arrhythmia (especially VT) and LPs are frequent in MVP. Patient age and mitral regurgitation seem to be determinant factors of complex ventricular arrhythmias in MVP. On signal-averaged ECG, absence of LPs seems to be a good additional marker to identify MVP patients without spontaneous VT. On the other hand, programmed ventricular stimulation does not appear valuable in determining a MVP subgroup with a high risk of ventricular arrhythmias.

Entities:  

Mesh:

Year:  1994        PMID: 7521034     DOI: 10.1111/j.1540-8159.1994.tb01466.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

1.  Fourier phase analysis of SPECT equilibrium radionuclide angiography in symptomatic patients with mitral valve prolapse without significant mitral regurgitation: assessment of biventricular functional abnormalities suggesting a cardiomyopathy.

Authors:  D Casset-Senon; D Babuty; L Philippe; L Fauchier; V Eder; J P Fauchier; J M Pottier; C Delhomme; P Cosnay
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

2.  Predictors of ventricular arrhythmias in patients with mitral valve prolapse.

Authors:  Yasin Turker; Mehmet Ozaydin; Gurkan Acar; Mustafa Ozgul; Yesim Hoscan; Ercan Varol; Abdullah Dogan; Dogan Erdogan; Habil Yucel
Journal:  Int J Cardiovasc Imaging       Date:  2009-10-22       Impact factor: 2.357

3.  Mitral valve prolapse and sudden cardiac arrest in the community.

Authors:  Kumar Narayanan; Audrey Uy-Evanado; Carmen Teodorescu; Kyndaron Reinier; Gregory A Nichols; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  Heart Rhythm       Date:  2015-09-28       Impact factor: 6.343

4.  Prolonged Tp-e Interval and Tp-e/QT Ratio in Children with Mitral Valve Prolapse.

Authors:  Mustafa Demirol; Cem Karadeniz; Rahmi Ozdemir; Şenay Çoban; Nagehan Katipoğlu; Yılmaz Yozgat; Timur Meşe; Nurettin Unal
Journal:  Pediatr Cardiol       Date:  2016-06-01       Impact factor: 1.655

5.  Mitral valve prolapse and electrolyte abnormality: a dangerous combination for ventricular arrhythmias.

Authors:  Ali Raza Rajani; Vagishwari Murugesan; Fahad Omar Baslaib; Muhammad Anwer Rafiq
Journal:  BMJ Case Rep       Date:  2014-05-14

6.  Autonomic dysregulation as a novel underlying cause of mitral valve prolapse: a hypothesis.

Authors:  Xiang Hu; Qiang Zhao
Journal:  Med Sci Monit       Date:  2011-09

7.  Mitral Valve Prolapse and Sudden Cardiac Death: A Systematic Review.

Authors:  Hui-Chen Han; Francis J Ha; Andrew W Teh; Paul Calafiore; Elizabeth F Jones; Jennifer Johns; Anoop N Koshy; David O'Donnell; David L Hare; Omar Farouque; Han S Lim
Journal:  J Am Heart Assoc       Date:  2018-12-04       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.